Does anamorelin have beneficial effects in advanced cancer patients with systemic inflammation in the real world?
Crossref DOI link: https://doi.org/10.1007/s10637-025-01537-4
Published Online: 2025-04-28
Published Print: 2025-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Amano, Koji
Naito, Tateaki
Baracos, Vickie E.
Text and Data Mining valid from 2025-04-01
Version of Record valid from 2025-04-01
Article History
Received: 11 March 2025
Accepted: 21 April 2025
First Online: 28 April 2025
Declarations
:
: The authors declare no competing interests.